NCT04920175

Brief Summary

The goal of this observational study is to collect data to develop a complete package (hardware, user interface software and algorithms) that can monitor sleep-wake stages in neonates. Real-time EEG data will be used to develop and refine the prototype monitor's ability to provide direct real-time information about sleep-wake state. The study design includes multiple iterative training/testing stages to refine the prototype. The study is divided into multiple sub-aims conducted in parallel: data acquisition, algorithm development (including comparison between gold-standard polysomnogram vs. novel algorithm markings of sleep-stages), and graphical user interface software development. The data acquisition and algorithm development are iterative and linked, such that the prototype algorithm from one iteration will be deployed real-time during the next iteration of data acquisition. This allows verification that the algorithm can perform real-time and provides prospective testing data, which is later folded into the training data for the next iteration, for verification and validation of the system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 9, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2024

Completed
Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

3.3 years

First QC Date

June 3, 2021

Last Update Submit

January 21, 2025

Conditions

Keywords

NICUNeonatal Sleep

Outcome Measures

Primary Outcomes (1)

  • Negative predictive value (NPV) for detection of sleep (any stage)

    Negative predictive value of monitor compared to gold-standard polysomnogram

    12 hours

Secondary Outcomes (5)

  • NPV for detection of REM sleep

    12 hours

  • NPV for detection of non-REM sleep

    12 hours

  • Positive predictive value (PPV) of Sleep

    12 hours

  • Positive predictive value (PPV) of REM sleep

    12 hours

  • Positive predictive value (PPV) of non-REM sleep

    12 hours

Study Arms (1)

NICU Cohort

Participants will undergo a standard polysomnogram

Other: Novel Real-time Neonatal Sleep Stage Detection Algorithm

Interventions

Comparison of Novel Real-time Neonatal Sleep Stage Detection Algorithm to gold standard concurrent polysomnogram.

NICU Cohort

Eligibility Criteria

Age1 Day - 1 Year
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Newborns admitted to the Newborn ICU in C\&W Mott Hospital

You may qualify if:

  • Admitted to the Newborn ICU in C\&W Mott Hospital
  • \>/= 30 weeks gestational age at the time of birth (\>/= 33 weeks post-conceptional age at enrollment)

You may not qualify if:

  • Any diagnosis, patient care, or anticipated patient care that is likely to interfere with the 12 hour recording or would make the recording dangerous to the participant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Infant, Newborn, Diseases

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • John Barks, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR
  • Stephen Gliske, PhD

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

June 3, 2021

First Posted

June 9, 2021

Study Start

September 1, 2021

Primary Completion

December 19, 2024

Study Completion

December 19, 2024

Last Updated

January 24, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations